| 摘要 |
The present invention relates to the use of a compound of formula (1) wherein Ris pyridyl or thiazolyl, any of which may optionally be substituted with Calkyl or Calkenyl; and a) Ris methoxy and n is zero or one; or b) Ris chlorine and n is zero and pharmaceutically acceptable salts thereof for lowering or controlling proteinuria, in particular for the treatment of diabetic nephropathy., (1) |
